Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Vagal AF Induction Test (VAFIT Protocol): A Novel Endpoint for Optimizing Atrial Fibrillation Ablation Outcomes through Cardioneuroablation
  • +5
  • Jose Pachon-M,
  • Enrique Indalecio Pachon,
  • Tomás Pena,
  • Tasso J. Lobo,
  • Carlos Pachón,
  • Juan Pachon,
  • Maria Pachon,
  • John Clark
Jose Pachon-M
Universidade de Sao Paulo

Corresponding Author:[email protected]

Author Profile
Enrique Indalecio Pachon
Universidade de Sao Paulo
Author Profile
Tomás Pena
Hospital do Coracao
Author Profile
Tasso J. Lobo
Hospital do Coracao
Author Profile
Carlos Pachón
Hospital do Coracao
Author Profile
Juan Pachon
Universidade de Sao Paulo
Author Profile
Maria Pachon
Hospital do Coracao
Author Profile
John Clark
Akron Children's Hospital
Author Profile

Abstract

Background Currently, there is no reliable endpoint for the conclusion of atrial fibrillation (AF) ablation. Atrial burst pacing and/or isoproterenol challenge are poor diagnostic tools. A newly proposed Vagal AF Induction Test(VAFIT) uses effective atrial refractory period measurement, simultaneously with extra-cardiac vagal stimulation(ECVS) to study AF inducibility pre and post-ablation. Objective Prospective study in patients submitted to radiofrequency catheter pulmonary vein isolation(PVI) plus cardioneuroablation(CNA) evaluating the VAFIT result before and at the end of the procedure with AF recurrence. Methods Prospective study of 142 patients, 57.5[48.9-70.2] years-old, 71% males, with symptomatic AF (79.6% paroxysmal/20.4% persistent), left atrium diameter of 38.0[35.0-41.2] mm, and left ventricular ejection fraction of 63.0 [62.0-68.2]. VAFIT was considered positive or negative depending on whether AF induction occurred. It was performed at baseline and after PVI+CNA, with a single atrial extra stimulus during ECVS (5s/50Hz/1V/kg up to 70V/Pulse Width=50 µs). Patients were followed for a median of 15.0[7.0-20.0] months. The association of VAFIT-positive status at the end of the procedure with AF recurrence was investigated by univariate and multivariate Cox regression analysis. Results Pre-ablation VAFIT was positive in all cases and became negative in 62.9% of patients. AF recurrence: 18.7% in VAFIT-positive and 5.6% in VAFIT-negative patients(p=0.012). VAFIT-positivity was associated with AF recurrence (HR: 4.56(1.37-15.23,p=0.014). Conclusion A VAFIT-positive status following PVI+CNA was strongly and independently associated with AF recurrence. It remains to be investigated in randomized studies whether achieving VAFIT-negativity at the end of the procedure, as demonstrated in this study, would lead to better clinical outcomes.
29 Sep 2024Submitted to Journal of Cardiovascular Electrophysiology
30 Sep 2024Review(s) Completed, Editorial Evaluation Pending
30 Sep 2024Submission Checks Completed
30 Sep 2024Assigned to Editor
04 Oct 2024Reviewer(s) Assigned